Updated Efficacy and Safety of Entrectinib in Patients (PTS) with NTRK Fusion-Positive (NTRK plus ) Tumors: Integrated Analysis of STARTRK-2, STARTRK-1, and ALKA-372-001
ONCOLOGY RESEARCH AND TREATMENT(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要